back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-20 17:57 Tx date 2023-12-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$37,697
+3,497 vol $10.78 each |
74,225 | |
| Filed 2023-12-20 17:55 Tx date 2023-12-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-37,697.66
-3,497 vol $10.78 each |
101,705 | |
| Filed 2023-12-20 17:52 Tx date 2023-12-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,871
+823 vol $10.78 each |
70,728 | |
| Filed 2023-12-20 17:50 Tx date 2023-12-19 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,871.94
-823 vol $10.78 each |
105,202 | |
| Filed 2023-06-05 13:31 Tx date 2023-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$719,786
+18,475 vol $38.96 each |
106,025 | |
| Filed 2023-05-06 12:27 Tx date 2023-04-25 |
$SVA
Sernova Corp. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+210,000 vol |
210,000 | |
| Filed 2023-05-06 11:18 Tx date 2021-06-30 |
$SVA
Sernova Corp. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-12-13 16:36 Tx date 2022-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$8,239
+3,086 vol $2.67 each |
69,905 | |
| Filed 2022-12-13 16:35 Tx date 2022-12-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-8,239.62
-3,086 vol $2.67 each |
87,550 | |
| Filed 2022-06-29 18:42 Tx date 2022-06-28 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$541,980
+18,000 vol $30.11 each |
90,636 | |
| Filed 2021-12-17 16:17 Tx date 2021-12-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,541
+3,086 vol $3.74 each |
66,819 | |
| Filed 2021-12-17 16:16 Tx date 2021-12-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,541.64
-3,086 vol $3.74 each |
72,636 | |
| Filed 2021-12-16 21:54 Tx date 2021-12-09 |
$SVA
Sernova Corp. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
56 - Grant of rights
|
+205,000 vol |
205,000 | |
| Filed 2021-12-16 21:52 Tx date 2021-06-30 |
$SVA
Sernova Corp. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Rights Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-03 21:40 Tx date 2021-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$185,600
+10,000 vol $18.56 each |
75,722 | |
| Filed 2020-12-15 16:49 Tx date 2020-12-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,541
+3,086 vol $3.74 each |
63,733 | |
| Filed 2020-12-15 16:48 Tx date 2020-12-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,541.64
-3,086 vol $3.74 each |
65,722 | |
| Filed 2020-06-02 19:41 Tx date 2020-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$131,100
+10,000 vol $13.11 each |
68,808 | |
| Filed 2019-12-17 17:22 Tx date 2019-12-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,541.64
-3,086 vol $3.74 each |
58,808 | |
| Filed 2019-12-17 17:19 Tx date 2019-12-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,541
+3,086 vol $3.74 each |
60,647 | |
| Filed 2019-09-18 21:29 Tx date 2019-09-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-214.1806
-23 vol $9.31 each |
57,561 | |
| Filed 2019-09-18 21:24 Tx date 2019-09-16 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$141,600
+15,000 vol $9.44 each |
61,894 | |
| Filed 2019-09-18 21:07 Tx date 2019-09-13 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-214.1806
-23 vol $9.31 each |
||
| Filed 2018-12-10 Tx date 2018-12-06 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,541
+3,086 vol $3.74 each |
57,584 | |
| Filed 2018-12-10 Tx date 2018-12-06 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,541.64
-3,086 vol $3.74 each |
46,894 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-10,288 vol |
49,980 | |
| Filed 2018-06-22 Tx date 2018-06-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$38,477
+10,288 vol $3.74 each |
54,498 | |
| Filed 2018-06-05 Tx date 2018-06-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$93,000
+15,000 vol $6.20 each |
60,268 | |
| Filed 2018-01-04 Tx date 2018-01-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-3,497 vol |
45,268 | |
| Filed 2017-11-16 Tx date 2017-11-15 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$33,280
+15,000 vol $2.22 each |
44,210 | |
| Filed 2017-09-25 Tx date 2017-09-22 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,600
+8,000 vol $2.95 each |
29,210 | |
| Filed 2017-09-25 Tx date 2017-09-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,900
+2,000 vol $2.95 each |
21,210 | |
| Filed 2017-08-21 Tx date 2017-08-18 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$18,301
+6,312 vol $2.90 each |
19,210 | |
| Filed 2017-08-21 Tx date 2017-08-17 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$60.95
+23 vol $2.65 each |
12,898 | |
| Filed 2017-06-02 Tx date 2017-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,475
+3,500 vol $3.85 each |
48,765 | |
| Filed 2016-12-02 Tx date 2016-12-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-46,170.30
-12,345 vol $3.74 each |
45,265 | |
| Filed 2016-12-02 Tx date 2016-12-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$29,684
+7,937 vol $3.74 each |
12,875 | |
| Filed 2016-06-03 Tx date 2016-06-02 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,830
+3,500 vol $7.38 each |
57,610 | |
| Filed 2015-12-14 Tx date 2015-12-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-14,986.83
-2,469 vol $6.07 each |
54,110 | |
| Filed 2015-12-14 Tx date 2015-12-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$14,986
+2,469 vol $6.07 each |
4,938 | |
| Filed 2015-05-07 Tx date 2015-05-04 |
$XENE
Xenon Pharmaceuticals Inc. |
Azab, Mohammad
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,086 vol |
56,579 |